How this trial has affected Deborah and her family
Deborah Sims is a young chronic lymphocytic leukaemia (CLL) patient, undertaking a clinical trial of obinutuzumab and venetoclax (ABT-199). Here, Deborah talks about the impact this clinical has had o...
Author: PatientPowerEU
Added: 04/11/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Clinical Trials | Leukemia